WAYNE, Pa., July 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the results of several research studies that further ...

WAYNE, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it is celebrating Men’s Health Month with the ...

Dr. Irina Jaeger, director of urology at University Hospitals Richmond Medical Center, is making UroLift treatment for benign prostatic hypertrophy, or BPH, available in the area for the first time.

NeoTract, a wholly owned subsidiary of Teleflex Incorporated TFX focused on addressing unmet needs in the field of urology, today announced that Michael Brame, M.D., Carolina Urology Partners in ...

Evidence supports the case for adopting the UroLift System for treating lower urinary tract symptoms of benign prostatic hyperplasia. The UroLift System relieves lower urinary tract symptoms, avoids ...

Allentown, Pa.-based Lehigh Valley Health Network’s Clifford Georges, MD, was named a UroLift Center of Excellence. 1. Dr. Georges was recognized for his high level of training and experience with ...

Pictured is the medical team and staff at the Jamestown division of Western New York Urology Associates, located at 117 Foote Ave. The practice was recently designated as one of eight “UroLift Centers ...

WAYNE, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that 200,000 patients have been treated with the minimally invasive UroLift® System for benign prostatic ...

Data Presented at European Association of Urology Highlights Safety and Versatility of the Minimally Invasive UroLift System in a Real-World Setting WAYNE, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- ...

Rates of surgical retreatment, alongside patient experience factors such as complications and adverse events (AEs), are important considerations when patients and their providers assess BPH therapies.

“Arriving at the intersection of effective BPH treatment, patient priorities and available technology can be a daunting task,” said Mr. Olly Kayes, MD, Honorary Senior Lecturer at the University of ...